Clinical stage draws nearer in ongoing studies of gene therapy
- PMID: 3880587
Clinical stage draws nearer in ongoing studies of gene therapy
Abstract
KIE: The state of the art in research on human gene therapy is summarized. Clinical trials are estimated to be at most three years away for some single gene defects, with current research focused on somatic cell rather than germline therapy. A gene therapy subcommittee of the National Institutes of Health's Recombinant DNA Advisory Committee is drafting guidelines for investigators who are planning to submit their research protocols to the committee for review.
Similar articles
-
Gene therapy: research in public.Science. 1985 Feb 1;227(4686):493-6. doi: 10.1126/science.3880924. Science. 1985. PMID: 3880924 Clinical Trial.
-
Gene therapy in the United States: a five-year status report.Hum Gene Ther. 1996 Sep 10;7(14):1781-90. doi: 10.1089/hum.1996.7.14-1781. Hum Gene Ther. 1996. PMID: 8886849 No abstract available.
-
National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.Recomb DNA Tech Bull. 1986 Dec;9(4):221-42. Recomb DNA Tech Bull. 1986. PMID: 3469693 No abstract available.
-
Scientific and ethical considerations in human gene therapy.Baillieres Clin Obstet Gynaecol. 1991 Sep;5(3):697-713. doi: 10.1016/s0950-3552(05)80265-2. Baillieres Clin Obstet Gynaecol. 1991. PMID: 1954734 Review. No abstract available.
-
The ethics of somatic and germline gene therapy.Ann N Y Acad Sci. 1997 Jun 17;816:378-82. doi: 10.1111/j.1749-6632.1997.tb52165.x. Ann N Y Acad Sci. 1997. PMID: 9238291 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical